Anouschka Akerman

SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern

Anupriya Aggarwal, Anouschka Akerman, Vanessa Milogiannakis et al. · EBioMedicine · 2022 · 159 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition

George Sharbeen, Joshua A. McCarroll, Anouschka Akerman et al. · Cancer Research · 2021 · 132 citations · Full text

Medicine, Cancer Biology, Oncology +17

SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern

Anupriya Aggarwal, Alberto Ospina Stella, Gregory J. Walker et al. · medRxiv · 2021 · 72 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia

Anupriya Aggarwal, Alberto Ospina Stella, Gregory J. Walker et al. · Nature Microbiology · 2022 · 57 citations · Full text

Life Sciences, Biology, Infectious Diseases +17

Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level

Anouschka Akerman, Vanessa Milogiannakis, Tyra Jean et al. · EBioMedicine · 2023 · 55 citations · Full text

Life Sciences, Immunology, Molecular Biology +15